Featured Research

from universities, journals, and other organizations

Protein Interactions Demonstrate That Alzheimer’s And Parkinson’s Disease May Share A Common Fiber

Date:
April 25, 2003
Source:
University Of Pennsylvania Medical Center
Summary:
The amyloid lesions that cause Alzheimer’s and Parkinson’s disease are made of clumps of tangled proteins, but these clumps are composed of different protein subunits. Researchers at the University of Pennsylvania School of Medicine have discovered, however, that the tau proteins found in Alzheimer’s disease and the alpha ()-synuclein proteins found in Parkinson’s disease can facilitate each other to form amyloid lesions in the laboratory.

Philadelphia, PA – The amyloid lesions that cause Alzheimer’s and Parkinson’s disease are made of clumps of tangled proteins, but these clumps are composed of different protein subunits. Researchers at the University of Pennsylvania School of Medicine have discovered, however, that the tau proteins found in Alzheimer’s disease and the alpha ()-synuclein proteins found in Parkinson’s disease can facilitate each other to form amyloid lesions in the laboratory.

Their findings, presented in this week’s issue of Science, provide insights into the mechanisms underlying both diseases and suggest that therapeutics developed for one disease might be efficacious for both.

“We are trying to understand the basic pathological overlap between the different amyloid lesions that cause Alzheimer’s and Parkinson’s, ” said Virginia M. -Y. Lee, PhD, professor in Penn’s Department of Pathology and Laboratory Medicine and Director of Penn’s Center for Neurodegenerative Disease Research (CNDR). “This fundamental relationship may explain why patients with one disease are more likely to exhibit signs of the other disease.”

The researchers showed that the -synuclein proteins that form Lewy bodies in Parkinson’s disease can induce tau proteins to form the sort of fiber aggregates found in Alzheimer’s disease. Moreover, interactions between the tau and the -synuclein proteins can dramatically induce the formation of fibrous clumps of both proteins.

“This newly uncovered interaction between these two proteins suggests that therapeutic agents created to directly or indirectly inhibit the formation of one form of amyloid lesion might be effective for treating other forms of amyloid lesions,” said Benoit Gaisson, PhD, lead author of the paper and researcher at the CNDR. “That is, a drug meant to keep Lewy bodies from forming to prevent Parkinson’s disease might also help prevent tau tangles from forming in Alzheimer’s disease.”

The two proteins, tau and -synuclein are naturally abundant in the brain, but have distinct functions. Tau has a binding role in the structures of neurons, while -synuclein is thought to be involved in regulating communications in the synapses between neurons.

The researchers knew that the smaller of the two proteins, -synuclein, could bind to itself in homogenous clumps. The tau protein, meanwhile, is larger and it requires co-factors to aid overcoming a folding threshold. While the Penn researchers initially demonstrated that -synuclein could aid tau into forming fibers in a test tube, the researchers also wanted to know if this also occurred in vivo. Using mouse models, they were able to demonstrate that -synuclein polymerization alone is sufficient to induce the assembly of tau clumps in cells of the brain. Moreover, they were able to demonstrate that the same phenomenon occurs in a similar group of individuals with a known genetic abnormality in the -synuclein gene.

“After this initial step, we see a cycle begin to emerge,” said Gaisson. “Tau and -synuclein work together to promote and propagate each other’s formation of fibrous clumps and, hence, the amyloid lesions that cause disease.”

Other scientists involved in the research paper described here include Mark S. Forman, Makoto Huguchi, Charles L. Graves, Paul T. Kotzbauer, and John Q. Trojanowski from Penn; and Lawrence I. Golbe from the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.

Funding for this research was supported by the National Institutes on Aging and by a Pioneer Award from the Alzheimer’s Association.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "Protein Interactions Demonstrate That Alzheimer’s And Parkinson’s Disease May Share A Common Fiber." ScienceDaily. ScienceDaily, 25 April 2003. <www.sciencedaily.com/releases/2003/04/030425072025.htm>.
University Of Pennsylvania Medical Center. (2003, April 25). Protein Interactions Demonstrate That Alzheimer’s And Parkinson’s Disease May Share A Common Fiber. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2003/04/030425072025.htm
University Of Pennsylvania Medical Center. "Protein Interactions Demonstrate That Alzheimer’s And Parkinson’s Disease May Share A Common Fiber." ScienceDaily. www.sciencedaily.com/releases/2003/04/030425072025.htm (accessed July 28, 2014).

Share This




More Mind & Brain News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com
University Quiz Implies Atheists Are Smarter Than Christians

University Quiz Implies Atheists Are Smarter Than Christians

Newsy (July 25, 2014) An online quiz from a required course at Ohio State is making waves for suggesting atheists are inherently smarter than Christians. Video provided by Newsy
Powered by NewsLook.com
Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins